482 related articles for article (PubMed ID: 20335954)
1. 3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: past, present and future.
Túnez I; Tasset I; Pérez-De La Cruz V; Santamaría A
Molecules; 2010 Feb; 15(2):878-916. PubMed ID: 20335954
[TBL] [Abstract][Full Text] [Related]
2. [Model of Huntington's disease induced with 3-nitropropionic acid].
Túnez I; Santamaría A
Rev Neurol; 2009 Apr 16-30; 48(8):430-4. PubMed ID: 19340784
[TBL] [Abstract][Full Text] [Related]
3. Rhes deletion is neuroprotective in the 3-nitropropionic acid model of Huntington's disease.
Mealer RG; Subramaniam S; Snyder SH
J Neurosci; 2013 Feb; 33(9):4206-10. PubMed ID: 23447628
[TBL] [Abstract][Full Text] [Related]
4. An Overview of the Pathophysiological Mechanisms of 3-Nitropropionic Acid (3-NPA) as a Neurotoxin in a Huntington's Disease Model and Its Relevance to Drug Discovery and Development.
Upadhayay S; Yedke NG; Rahi V; Singh S; Kumar S; Arora A; Chandolia P; Kaur P; Kumar M; Koshal P; Jamwal S; Kumar P
Neurochem Res; 2023 Jun; 48(6):1631-1647. PubMed ID: 36738367
[TBL] [Abstract][Full Text] [Related]
5. Effect of Praeruptorin C on 3-nitropropionic acid induced Huntington's disease-like symptoms in mice.
Wang L; Wang J; Yang L; Zhou SM; Guan SY; Yang LK; Shi QX; Zhao MG; Yang Q
Biomed Pharmacother; 2017 Feb; 86():81-87. PubMed ID: 27939523
[TBL] [Abstract][Full Text] [Related]
6. Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms.
Kumar P; Padi SS; Naidu PS; Kumar A
Behav Pharmacol; 2006 Sep; 17(5-6):485-92. PubMed ID: 16940769
[TBL] [Abstract][Full Text] [Related]
7. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid.
Guyot MC; Hantraye P; Dolan R; Palfi S; Maziére M; Brouillet E
Neuroscience; 1997 Jul; 79(1):45-56. PubMed ID: 9178864
[TBL] [Abstract][Full Text] [Related]
8. Elderberry diet ameliorates motor function and prevents oxidative stress-induced cell death in rat models of Huntington disease.
Moghaddam MH; Bayat AH; Eskandari N; Abdollahifar MA; Fotouhi F; Forouzannia A; Rafiei R; Hatari S; Seraj A; Shahidi AMEJ; Ghorbani Z; Peyvandi AA; Aliaghaei A
Brain Res; 2021 Jul; 1762():147444. PubMed ID: 33745925
[TBL] [Abstract][Full Text] [Related]
9. Nicotinamide reverses behavioral impairments and provides neuroprotection in 3-nitropropionic acid induced animal model ofHuntington's disease: implication of oxidative stress- poly(ADP- ribose) polymerase pathway.
Sidhu A; Diwan V; Kaur H; Bhateja D; Singh CK; Sharma S; Padi SSV
Metab Brain Dis; 2018 Dec; 33(6):1911-1921. PubMed ID: 30054774
[TBL] [Abstract][Full Text] [Related]
10. Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington's disease model in rats.
Suganya SN; Sumathi T
Metab Brain Dis; 2017 Apr; 32(2):471-481. PubMed ID: 27928694
[TBL] [Abstract][Full Text] [Related]
11. Rhes, a key element of selective neuronal vulnerability in Huntington's disease: a striatal-specific license to kill during energy metabolism failure.
Ghiglieri V; Calabresi P
Mov Disord; 2013 Jun; 28(6):735. PubMed ID: 23712467
[No Abstract] [Full Text] [Related]
12. Altered microRNA regulation in Huntington's disease models.
Lee ST; Chu K; Im WS; Yoon HJ; Im JY; Park JE; Park KH; Jung KH; Lee SK; Kim M; Roh JK
Exp Neurol; 2011 Jan; 227(1):172-9. PubMed ID: 21035445
[TBL] [Abstract][Full Text] [Related]
13. NR2B subunit blockade does not affect motor symptoms induced by 3-nitropropionic acid.
Fantin M; Morari M; Tison F; Fernagut PO
Neurol Res; 2011 May; 33(4):444-7. PubMed ID: 21535946
[TBL] [Abstract][Full Text] [Related]
14. Systemic, but not intraparenchymal, administration of 3-nitropropionic acid mimics the neuropathology of Huntington's disease: a speculative explanation.
Borlongan CV; Nishino H; Sanberg PR
Neurosci Res; 1997 Jul; 28(3):185-9. PubMed ID: 9237266
[TBL] [Abstract][Full Text] [Related]
15. 3-nitropropionic acid model of metabolic stress: assessment by magnetic resonance imaging.
Roberts TJ
Methods Mol Med; 2005; 104():203-20. PubMed ID: 15454669
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington's disease.
Lee WT; Chang C
Prog Neurobiol; 2004 Feb; 72(2):87-110. PubMed ID: 15063527
[TBL] [Abstract][Full Text] [Related]
17. Potential of protease inhibitor in 3-nitropropionic acid induced Huntington's disease like symptoms: mitochondrial dysfunction and neurodegeneration.
Hariharan A; Shetty S; Shirole T; Jagtap AG
Neurotoxicology; 2014 Dec; 45():139-48. PubMed ID: 25445565
[TBL] [Abstract][Full Text] [Related]
18. The 3-NP Model of Striatal Neurodegeneration.
Brouillet E
Curr Protoc Neurosci; 2014 Apr; 67():9.48.1-9.48.14. PubMed ID: 24723322
[TBL] [Abstract][Full Text] [Related]
19. Melatonin protects against behavioural dysfunctions and dendritic spine damage in 3-nitropropionic acid-induced rat model of Huntington's disease.
Chakraborty J; Nthenge-Ngumbau DN; Rajamma U; Mohanakumar KP
Behav Brain Res; 2014 May; 264():91-104. PubMed ID: 24509309
[TBL] [Abstract][Full Text] [Related]
20. Autophagy as a neuroprotective mechanism against 3-nitropropionic acid-induced murine astrocyte cell death.
Pereira GJ; Tressoldi N; Hirata H; Bincoletto C; Smaili SS
Neurochem Res; 2013 Nov; 38(11):2418-26. PubMed ID: 24085658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
